Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Refolding Technologies for Antibody Fragments

View through CrossRef
Refolding is one of the production technologies for pharmaceutical grade antibody fragments. Detergents and denaturants are primarily used to solubilize the insoluble proteins. The solubilized and denatured proteins are refolded by reducing the concentration of the denaturants or detergents. Several refolding technologies have been used for antibody fragments, comprising dilution, dialysis, solid phase solvent exchange and size exclusion chromatography, as reviewed here. Aggregation suppressor or folding-assisting agents, including arginine hydrochloride, ionic liquids and detergents or denaturants at low concentrations, are included in the refolding solvent to enhance refolding yield.
Title: Refolding Technologies for Antibody Fragments
Description:
Refolding is one of the production technologies for pharmaceutical grade antibody fragments.
Detergents and denaturants are primarily used to solubilize the insoluble proteins.
The solubilized and denatured proteins are refolded by reducing the concentration of the denaturants or detergents.
Several refolding technologies have been used for antibody fragments, comprising dilution, dialysis, solid phase solvent exchange and size exclusion chromatography, as reviewed here.
Aggregation suppressor or folding-assisting agents, including arginine hydrochloride, ionic liquids and detergents or denaturants at low concentrations, are included in the refolding solvent to enhance refolding yield.

Related Results

Online monitoring of protein refolding in inclusion body processing using intrinsic fluorescence
Online monitoring of protein refolding in inclusion body processing using intrinsic fluorescence
Abstract Inclusion bodies (IBs) are protein aggregates formed as a result of overexpression of recombinant protein in E. coli. The formation of IBs is a valuable st...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
Mesoscale Modeling of a Nucleosome-Binding Antibody (PL2-6): Mono- vs. Bivalent Chromatin Complexes
ABSTRACTVisualizing chromatin adjacent to the nuclear envelope (denoted “epichromatin”) by in vitro immunostaining with a bivalent nucleosome-binding antibody (termed monoclonal an...
Hsc70/Hsp40 chaperone system mediates the Hsp90‐dependent refolding of firefly luciferase
Hsc70/Hsp40 chaperone system mediates the Hsp90‐dependent refolding of firefly luciferase
BackgroundThe 90‐kDa heat shock protein, Hsp90, was previously shown to capture firefly luciferase during thermal inactivation, thereby preventing its irreversible off‐pathway aggr...
Immune-induced antibody-DNA hybrid condensates
Immune-induced antibody-DNA hybrid condensates
We report here the combined use of Watson-Crick and antibody-antigen interactions to induce phase separation of DNA-antibody hybrid condensates. To achieve this, we have used an an...

Back to Top